How many clinical trials are studying UCAR T-cell?

4 recruiting trials in our tracked data involve UCAR T-cell.

What conditions is UCAR T-cell being studied for?

In our tracked recruiting trials, UCAR T-cell is being studied in trials for Lupus, Multiple Sclerosis, Systemic Sclerosis (SSc).

Recruiting trials

Conditions studied

US states with sites

Countries

Early Phase 1 2 Phase 1 2

Condition	Trials
Lupus · UCAR T-cell for Lupus	3
Multiple Sclerosis · UCAR T-cell for Multiple Sclerosis	3
Systemic Sclerosis (SSc) · UCAR T-cell for Systemic Sclerosis (SSc)	3
ANCA Associated Systemic Vasculitis	2
Autoimmune Diseases	2
IgA Nephropathy (IgAN)	2
Multi-Drug Resistant Nephrotic Syndrome	2
Systemic Lupus Erthematosus (SLE)	2
ANCA-Associated Vasculitis (AAV)	1
Autoimmune Encephalitis	1
Chronic Inflammatory Demyelinating Polyradiculoneuropathy	1
Connective Tissue Disease-Associated Thrombocytopenia	1
Inflammatory Myopathy	1
Myasthenia Gravis	1
Neuromyelitis Optica Spectrum Disorders	1

Allogeneic CD19/BCMA CAR-T for B Cell-Related Autoimmune Disease
NCT07507201 · Phase: Early Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · 1 location
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With B Cell Mediated Autoimmune Disease
NCT07305116 · Phase: Phase 1 · Ages: 3 Years and older · Sex: All (male and female) · 1 location
CAR T-cell Therapy Targeting CD19 and BCMA in Patients With Relapse/Refractory Autoimmune Diseases
NCT06941129 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
Universal Chimeric Antigen Receptor T-Cell （UCAR T-cell） Therapy Targeting CD19/B Cell Maturation Antigen （CD19/BCMA） in Patients With r/r Neurological Autoimmune Diseases
NCT06939166 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location